Search

everythinglearnresearchcommunity

for

Search:↓

The Swedish neonatal screening program effectively detects PKU, galactosaemia, and biotinidase deficiency with low false positives.

Gefitinib can cause hair loss without scarring.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Baricitinib helps treat severe hair loss in people over 65.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

GRF is not safe for tubal occlusion.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

The method produces finasteride with a 92% yield.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Baricitinib improved hair loss and arthritis in a lupus patient.